Question 1

What is the catalog number for FSHMD1B Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)?

Accepted Answer

The catalog number for FSHMD1B Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA) is LV726264.

Question 2

Is FSHMD1B Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA) in stock?

Accepted Answer

FSHMD1B Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

What should I check when this product first arrives?

Accepted Answer

Inspect the package immediately for transportation damage, ice loss, leakage, or breakage. Report any issues right away with photos and your order reference; our specialists will determine whether the product is still usable or needs replacing.

Question 4

Does this cell line or biologic require a Material Transfer Agreement (MTA)?

Accepted Answer

Some products, including certain cell lines, plasmids, and tissue cultures, are subject to intellectual property terms and may require an MTA before we can ship. We’ll inform you in advance if this product requires one, and additional handling fees may apply.

Question 5

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

FSHMD1B Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

Product Specifications

Frequently Asked Questions

Explore Other Products

Anti-ARSA Antibody Picoband® (monoclonal, 4C10), Dylight594 Conjugate

Anti-SHQ1 Antibody Picoband®, Cy3 Conjugate

Anti-CGAS Antibody Picoband®, FITC Conjugate

Tyrosinase (OCA1/812), CF640R conjugate, 0.1mg/mL

CD40 / TNFRSF5 / CD40L-Receptor (T8P2G4*A6), CF405S conjugate, 0.1mg/mL

Cytokeratin 5+6 Mouse Monoclonal Antibody [A2A12]